Dermatology · Riverside, CA
NPI
1558540773
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10800 Magnolia Avenue
Riverside, CA, 92505
Phone (949) 748-7570
Groups this clinician bills Medicare through
Medicare paid, 2024
$241
17 services
Medicare patients, 2024
11
Average age 65
Drug cost, 2024
$556K
1,529 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Felicia Schwab-Doyle prescribed most often to Medicare patients was Clobetasol Propionate, with 152 prescriptions and refills. In total Felicia Schwab-Doyle wrote 1,529 Medicare prescriptions that cost $556K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 152 | 155 | 81 | $4,219 |
| Fluocinonide Generic | 137 | 147 | 78 | $2,802 |
| Fluorouracil Generic | 111 | 113 | 96 | $4,116 |
| Calcipotriene Generic | 105 | 109 | 90 | $8,342 |
| Ketoconazole Generic | 87 | 87 | 44 | $1,322 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 79 | 84 | 42 | $3,704 |
| Tacrolimus Generic | 63 | 68 | 42 | $5,674 |
| Retin-A Tretinoin | 48 | 57 | 21 | $2,028 |
| Acitretin Generic | 46 | 46 | Under 11 | $4,537 |
| Fluocinolone Acetonide Generic | 46 | 55 | 20 | $1,646 |
| Triamcinolone Acetonide Generic | 46 | 51 | 30 | $1,191 |
| Nystatin Generic | 42 | 42 | 22 | $1,613 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 41 | 45 | Under 11 | $55K |
| Vectical Calcitriol | 36 | 37 | 19 | $6,396 |
| Hydrocortisone Generic | 32 | 35 | 25 | $541 |
Brand drugs: 396 claims; generic drugs: 1,133 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Felicia Schwab-Doyle were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.